• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

DNA Repair Pathway Alterations in Metastatic Castration-resistant Prostate Cancer Responders to Radium-223.

作者信息

Ramos Jorge D, Mostaghel Elahe A, Pritchard Colin C, Yu Evan Y

机构信息

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Medicine, Division of Oncology, University of Washington, Seattle, WA.

Department of Laboratory Medicine, University of Washington, Seattle, WA.

出版信息

Clin Genitourin Cancer. 2018 Apr;16(2):106-110. doi: 10.1016/j.clgc.2017.11.009. Epub 2017 Dec 6.

DOI:10.1016/j.clgc.2017.11.009
PMID:29287968
Abstract
摘要

相似文献

1
DNA Repair Pathway Alterations in Metastatic Castration-resistant Prostate Cancer Responders to Radium-223.转移性去势抵抗性前列腺癌对镭-223有反应者的DNA修复途径改变
Clin Genitourin Cancer. 2018 Apr;16(2):106-110. doi: 10.1016/j.clgc.2017.11.009. Epub 2017 Dec 6.
2
Lymph Node Response in a Patient With Metastatic Castration-resistant Prostate Cancer Treated With Radium-223.用镭-223治疗的转移性去势抵抗性前列腺癌患者的淋巴结反应
Clin Genitourin Cancer. 2018 Apr;16(2):e397-e401. doi: 10.1016/j.clgc.2017.10.024. Epub 2017 Nov 7.
3
Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects.镭-223 治疗伴有和不伴有同源修复基因缺陷的骨转移去势抵抗性前列腺癌的疗效。
Eur Urol. 2019 Aug;76(2):170-176. doi: 10.1016/j.eururo.2018.09.040. Epub 2018 Oct 4.
4
Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer.镭-223 在有骨转移去势抵抗性前列腺癌的男性中的药效动力学研究。
PLoS One. 2019 May 28;14(5):e0216934. doi: 10.1371/journal.pone.0216934. eCollection 2019.
5
Circulating Tumor Cells as a Biomarker of Survival and Response to Radium-223 Therapy: Experience in a Cohort of Patients With Metastatic Castration-Resistant Prostate Cancer.循环肿瘤细胞作为生存和镭-223 治疗反应的生物标志物：转移性去势抵抗性前列腺癌患者队列的经验。
Clin Genitourin Cancer. 2018 Dec;16(6):e1133-e1139. doi: 10.1016/j.clgc.2018.07.013. Epub 2018 Jul 21.
6
Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer.DNA 损伤修复缺陷对镭-223 治疗转移性去势抵抗性前列腺癌及总生存的影响。
Eur J Cancer. 2020 Sep;136:16-24. doi: 10.1016/j.ejca.2020.05.001. Epub 2020 Jul 4.
7
Counterpoints: Which should be used first in symptomatic metastatic castration-resistant prostate cancer, docetaxel or radium? Radium-223 is the preferred therapy in bone-predominant symptomatic metastatic castration-resistant prostate cancer.反驳观点：在有症状的转移性去势抵抗性前列腺癌中，多西他赛和镭-223应首先使用哪一种？镭-223是骨转移为主的有症状转移性去势抵抗性前列腺癌的首选治疗方法。
Clin Adv Hematol Oncol. 2015 May;13(5):293-8.
8
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.基因畸变对镭-223治疗骨转移去势抵抗性前列腺癌疗效的影响。
Prostate. 2023 May;83(6):613. doi: 10.1002/pros.24489. Epub 2023 Jan 30.
9
Optimal usage of radium-223 in metastatic castration-resistant prostate cancer.镭-223 在转移性去势抵抗性前列腺癌中的最佳应用。
J Formos Med Assoc. 2017 Nov;116(11):825-836. doi: 10.1016/j.jfma.2017.04.005. Epub 2017 Oct 16.
10
Acute Promyelocytic Leukemia After Treatment of Metastatic Castration-Resistant Prostate Cancer With Radium-223.用镭-223治疗转移性去势抵抗性前列腺癌后发生的急性早幼粒细胞白血病
Clin Genitourin Cancer. 2017 Jun;15(3):e501-e502. doi: 10.1016/j.clgc.2016.12.028. Epub 2016 Dec 29.

引用本文的文献

1
The Tight Relationship Between the Tumoral Microenvironment and Radium-223.肿瘤微环境与镭-223之间的紧密关系
Biomedicines. 2025 Feb 12;13(2):456. doi: 10.3390/biomedicines13020456.
2
Predictive and Prognostic F-Fluorocholine PET/CT Radiomics Nomogram in Patients with Castration-Resistant Prostate Cancer with Bone Metastases Treated with Ra.镭治疗的去势抵抗性前列腺癌伴骨转移患者中预测性和预后性F-氟胆碱PET/CT影像组学列线图
Cancers (Basel). 2024 Jul 29;16(15):2695. doi: 10.3390/cancers16152695.
3
Radium-223 Treatment of Patients with Metastatic Castration Resistant Prostate Cancer: Biomarkers for Stratification and Response Evaluation.
镭-223治疗转移性去势抵抗性前列腺癌患者：用于分层和疗效评估的生物标志物
Cancers (Basel). 2021 Aug 27;13(17):4346. doi: 10.3390/cancers13174346.
4
Immune Inflammation Pathways as Therapeutic Targets to Reduce Lethal Prostate Cancer in African American Men.免疫炎症途径作为降低非裔美国男性致命性前列腺癌的治疗靶点
Cancers (Basel). 2021 Jun 9;13(12):2874. doi: 10.3390/cancers13122874.
5
Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center.镭-223 治疗转移性去势抵抗性前列腺癌：美国一家三级肿瘤中心的回顾性研究。
Prostate Cancer Prostatic Dis. 2021 Mar;24(1):210-219. doi: 10.1038/s41391-020-00271-7. Epub 2020 Aug 19.
6
Radium-223 mechanism of action: implications for use in treatment combinations.镭-223 的作用机制：对联合治疗应用的启示。
Nat Rev Urol. 2019 Dec;16(12):745-756. doi: 10.1038/s41585-019-0251-x. Epub 2019 Nov 11.
7
Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases.镭-223 再治疗：在去势抵抗性前列腺癌和骨转移患者中进行的国际、开放标签、1/2 期研究的 2 年随访结果。
Prostate. 2019 Oct;79(14):1683-1691. doi: 10.1002/pros.23893. Epub 2019 Aug 23.
8
Advances in targeted alpha therapy for prostate cancer.
Ann Oncol. 2019 Nov 1;30(11):1728-1739. doi: 10.1093/annonc/mdz270.
9
Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects.镭-223 治疗伴有和不伴有同源修复基因缺陷的骨转移去势抵抗性前列腺癌的疗效。
Eur Urol. 2019 Aug;76(2):170-176. doi: 10.1016/j.eururo.2018.09.040. Epub 2018 Oct 4.